Cargando…
The stent in the high-bleeding risk patient: antiplatelet monotherapy?
Dual antiplatelet therapy (DAPT) is the recommended treatment after percutaneous coronary intervention (PCI). The introduction into clinical practice of new drug-eluting stents (DESs) with significantly improved safety profiles has made it possible to shorten the DAPT. Randomized studies have establ...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653147/ https://www.ncbi.nlm.nih.gov/pubmed/36380796 http://dx.doi.org/10.1093/eurheartjsupp/suac074 |